Live Poll Results — Which COVID-19 vaccine holds the distinction of being the first to receive FDA E

See real-time poll results. Powered by AIPolls.Net.

Pharmaceutical Product Launch Milestones

The journey from drug development to market availability is complex and highly regulated in the medical industry. This poll tests your knowledge about one of the most significant pharmaceutical product launches in recent medical history. Understanding the timeline and milestones of groundbreaking medical products helps appreciate the innovation process in healthcare.

Which COVID-19 vaccine holds the distinction of being the first to receive FDA Emergency Use Authorization in the United States?

Poll Type: Trivia | Total Votes: 0

OptionVotesPercentage
{'choice_text': 'Pfizer-BioNTech COVID-19 Vaccine (December 11, 2020)', 'is_correct': True}00%
{'choice_text': 'Moderna COVID-19 Vaccine (December 18, 2020)', 'is_correct': False}00%
{'choice_text': "Johnson & Johnson's Janssen COVID-19 Vaccine (February 27, 2021)", 'is_correct': False}00%
{'choice_text': 'AstraZeneca COVID-19 Vaccine (Never received FDA EUA in the US)', 'is_correct': False}00%